Accessibility Menu
Convatec Group Plc logo

Convatec Group Plc(OTC) CNVVY

Market Cap$6.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+15%
5 Year+10%
1 Year+3%
1 Month+12%
$12.58
+0.60%
+0.07Today
Convatec Group Plc last closing stock price
MetricPriceDate
Last closeUSD 12.502026-08-13
Convatec Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.71%USD 12.292026-08-06
1 month+11.51%USD 11.212026-07-14
3 month+13.95%USD 10.972026-05-15
Year to date-2.77%USD 12.862025-12-31
1 year+3.06%USD 12.132025-08-13
3 year+17.61%USD 10.632023-08-10
5 year+10.47%USD 11.322021-08-13
Since inception+15.2%USD 10.852017-01-26

Convatec Group Plc Financials at a Glance

Market Cap

$6.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.84B

Net Income (TTM)

$339.50M

EPS (TTM)

$0.25

P/E Ratio

50.61

Dividend

$0.29

Beta (Volatility)

0.29 (Low)

Price

$12.58

Volume

168,713

Open

$12.44

Previous Close

$12.50

Daily Range

$12.35 - $12.63

52-Week Range

$10.45 - $14.09

Estimated Earnings Date

Feb 23, 2027

CNVVY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Convatec Group Plc

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company focuses on advanced wound care, ostomy care, and continence solutions, addressing the needs of patients with various medical conditions.

Products and Services
  • Advanced wound care solutions for acute and chronic wounds
  • Comprehensive ostomy care devices and support services
  • Continence and critical care products for urological disorders
Growth Outlook
  • Revenue growth of 6.5% year-over-year in Q4 2025
  • Strong demand for wound care products driven by aging population
  • Expansion into emerging markets expected to enhance market share
Financial Highlights
  • Q4 2025 net income of $69.9 million, reflecting a 6.5% increase
  • Trailing twelve months (TTM) revenue of $4.8 billion, indicating steady growth
  • Dividend yield of 2.34%, showcasing commitment to shareholder returns
ConvaTec Group Plc has established itself as a leader in the medical technology sector, with a diverse product portfolio that addresses critical healthcare needs. The company's focus on innovation and quality positions it well for future growth, particularly in the wound care and ostomy markets. Recent financial performance indicates a positive trajectory, with increasing revenues and net income, reflecting effective management and operational efficiency. The commitment to returning value to shareholders through dividends further enhances its appeal to potential investors. With ongoing expansion efforts and a strong market presence, ConvaTec presents a compelling opportunity in the healthcare industry.
AI Generated • Jul 29, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,910

CEO

Jonathan Peter Mason, MBA

Website

www.convatec.com

Headquarters

London, GL W2 6LG, GB

CNVVY Financials

Key Financial Metrics (TTM)

Gross Margin

55.07%

Operating Margin

16.16%

Net Income Margin

4.99%

Return on Equity

8.40%

Return on Capital

13.44%

Return on Assets

3.26%

Earnings Yield

1.98%

Dividend Yield

2.31%

Payout Ratio

1.12%

Stock Overview

Market Cap

$6.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

487.35M

Volume

168.71K

Avg. Volume

33.06K

Financials (TTM)

Gross Profit

$2.67B

Operating Income

$765.76M

EBITDA

$1.21B

Operating Cash Flow

$857.80M

Capital Expenditure

-$319.85M

Free Cash Flow

$537.95M

Cash & ST Invst.

$99.00M

Total Debt

$1.74B

Convatec Group Plc Performance Analysis

Convatec Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,071,220,9781.6%
20232023-12-31USD 2,150,704,0963.8%
20242024-12-31USD 2,290,163,2706.5%
20252025-12-31USD 2,444,699,6286.7%
Convatec Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.7%
Q22025-06-300.3%
Q42025-12-316.3%
Q22026-06-30-1.8%
Convatec Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.12-46.9%
20232023-12-31USD 0.25106.9%
20242024-12-31USD 0.3745.4%
20252025-12-31USD 0.34-6.9%
Convatec Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3141.1%
Q22025-06-30-5.4%
Q42025-12-31-31.4%
Q22026-06-30-21.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.23B

+10.6%

Gross Profit

$668.87M

+7.2%

Gross Margin

54.30%

N/A

Market Cap

$6.09BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$558.38K

N/A

Employees

10,910

N/A

Net Income

$53.99M

-31.3%

EBITDA

$290.95M

+16.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$99.00M

+2.2%

Total Debt

$1.74B

+23.3%

Accounts Receivable

$456.00M

+32.7%

Inventory

$435.00M

+14.9%

Long Term Debt

$1.72B

+23.4%

Short Term Debt

$25.00M

-40.2%

Return on Assets

3.26%

N/A

Return on Invested Capital

12.22%

N/A

Free Cash Flow

-$55.99M

-344.5%

Operating Cash Flow

$71.99M

-2.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SHPMYShanghai Pharmaceuticals Holding Co., Ltd
$7.47+0.00%
GNGBYGetinge AB (publ)
$25.16+0.71%
SKHCFSonic Healthcare Limited
$14.25+0.00%
SSMXYSysmex Corporation
$12.02+1.49%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.06+0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.69+0.01%
ONDSOndas
$9.14+0.03%
SPCXSpace Exploration Technologies
$139.49-0.01%

Questions About CNVVY

What is the current price of Convatec Group Plc?

Convatec Group Plc is trading at $12.58 per share.

What is the 52-week range for Convatec Group Plc?

Over the past 52 weeks, Convatec Group Plc has traded between $10.45 and $14.09.

How much debt does Convatec Group Plc have?

As of the most recent reporting period, Convatec Group Plc reported total debt of $1.52B.

How much cash does Convatec Group Plc have on hand?

Convatec Group Plc reported $75.00M in cash and cash equivalents in its most recent financial results.

What is Convatec Group Plc’s dividend yield?

Convatec Group Plc currently has a dividend yield of 2.31%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services